I
Insilixa
Organization focused on using high tech dna testing for detection and treatment of pathogens that are antibiotic resistant
About Insilixa
Insilixa operates in the biotechnology sector, specializing in advanced DNA testing technologies. The company offers a highly sensitive and specific nucleic acid analysis platform capable of detecting multiple organisms in clinical samples and identifying drug-resistant mutations. This technology is designed to provide rapid, actionable results within one hour, making it suitable for use in various settings, from hospitals to low-resource clinics. Insilixa's core clients include healthcare providers, hospitals, and clinics that require fast and accurate diagnostic solutions to combat infections and sepsis, which are leading causes of death in non-cardiac ICUs. The company generates revenue through the sale of its DNA testing platforms and associated cloud-based analysis and reporting services. By addressing the urgent need for rapid and reliable diagnostic tools, Insilixa positions itself as a crucial player in the fight against antibiotic-resistant pathogens and emerging viral threats.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2011
- Headquarters
- Sunnyvale, United States
- Employees
- 6
- Open positions
- None listed
- Dealroom signal
- 64.3/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Testing, Biotechnology, DNA, Genetics and genomics, Spinout, Genome Engineering, Biotech and Pharma, medical testing, DT and LS, science-based
- Technology
- Deep Tech
- Client focus
- b2b
Latest news
Press, funding announcements and product moves mentioning Insilixa.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Oct 2014 | $13M | $52M | PointGuard Ventures · Morningside | — |
| SPINOUT✓Other financing | Jan 2011 | $0 | — | Caltech, California Institute of Technology · Stanford University · University of Texas at Austin | — |
Growth signals
Latest recorded traffic for Insilixa is 270 monthly website visits, down 15.6% over the last three months. Insilixa's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later2 investors entered at this stage
- PVPointGuard Ventures
Morningside
Other known investors4 additional known investors
Caltech, California Institute of Technology
Stanford University
University of Texas at Austin
Small Business Innovation Research
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Insilixa on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Insilixa’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.